Company Overview

CORBUS PHARMACEUTICALS HOLDINGS, INC.

CRBP
Annual
Revenue vs. Cost of Revenue
Revenue Cost of Revenue
Total Operating Expenses vs. Operating Income
Total Operating Expenses Operating Income
Net Income
Net Income
Revenue
6M
2025 FY
Net Income
-79M
2025 FY
Shares Outstanding
13M
2025 FY
EPS
-5.9USD
2025 FY
Company Information
SIC Code
2834
CIK Code
1595097
Exchange
Nasdaq
Location
US